[ASND] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -21.07%
YoY- -64.58%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 746 2,225 5,414 28 372 1,258 2,081 -15.70%
PBT -62,983 -63,394 -53,707 -41,482 -25,153 -20,636 1,468 -
Tax -191 -77 -70 -107 -14 -118 46 -
NP -62,792 -63,317 -53,637 -41,375 -25,139 -20,518 1,422 -
Tax Rate - - - - - - -3.13% -
Total Cost 63,538 65,542 59,051 41,403 25,511 21,776 659 113.98%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -8,417.16 -2,845.71 -990.71 -147,767.86 -6,757.80 -1,631.00 68.33 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -1.17 -1.32 -1.24 -1.07 -0.78 -0.82 0.07 -
EPS Diluted -1.17 -1.32 -1.24 -1.07 -0.78 -0.82 0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.